TABLE OF CONTENTS:
I. Avenir Award Program for Chemistry and Pharmacology of Substance Use Disorders (DP1- Clinical Trial Not Allowed) RFA-DA-23-014
II. A Multi-omics Approach to Immune Responses in HIV Vaccination and Intervention (P01 Clinical Trial Not Allowed) RFA-AI-22-038
V. Early Career Investigator Showcases Applications (NIDA-NIAAA Frontiers in Addiction Research Mini-Convention)
VI. NIDA Early Career Workshop at CPDD
-----
I. Avenir Award Program for Chemistry and Pharmacology of Substance Use Disorders (DP1- Clinical Trial Not Allowed) RFA-DA-23-014
The purpose of this award is to support early stage investigators proposing highly innovative research in the area of chemistry and pharmacology of substance use disorders and addiction. This award is to support those in an early stage of their career who may lack the preliminary data required for an R01 grant, but who propose high impact research and who show promise of being tomorrow's leaders in the field. The research may focus on development of novel chemical, pharmacological, or computational methods and tools that can potentially be applied to investigate basic mechanisms, targets, and pathways of relevance to treating addiction and substance use disorders. Investigators outside the field of addiction who are interested in applying their novel approaches to the chemistry and pharmacology of addiction are encouraged to apply.
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-014.html
Letter of Intent due July 11, 2022 and applications are due Aug 11, 2022.
II. A Multi-omics Approach to Immune Responses in HIV Vaccination and Intervention (P01 Clinical Trial Not Allowed) RFA-AI-22-038
The purpose of this Funding Opportunity Announcement (FOA) is to support multi-disciplinary, multi-component applications proposing the use of omics technologies to advance preventative and/or therapeutic vaccinations, and/or immunomodulatory cure interventions for HIV. Projects will integrate omics, computational, and hypothesis-driven experimental approaches to interrogate immune responses to HIV vaccination and/or cure strategies.
https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-22-038.html
Applications are due October 13, 2022.
III. Transformative Research on the Basic Mechanisms of Polysubstance use in Addiction (R01 - Clinical Trial Not Allowed) RFA-DA-23-015
The purpose of this funding opportunity announcement is to support projects proposing mechanistic studies that will transform our understanding of polysubstance use in addiction. NIDA is specifically interested in hypothesis-based, exploratory projects that investigate the mechanisms of polysubstance use at the behavioral, cognitive, cellular, circuit, genetic, epigenetic, pharmacological and/or computational levels.
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-015.html
Letter of Intent due October 14, 2022 and applications are due November 14, 2022.
IV. Notice of Special Interest (NOSI): Administrative Supplement for Research Efforts that Illuminate Fundamental Processes Underlying Behavior Change, Maintenance, and Adherence (Admin Supp Clinical Trial Optional) NOT-OD-22-140
One-year administrative supplements are available for parent projects that have at least two (2) full years of active funding (excluding no-cost extension periods) remaining at the time of submission.
Potential NIDA applicants can contact Holly Moore at holly.moore@nih.gov.
For full description of this opportunity, see link below
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-22-140.html.
Applications are due July 15, 2022.
V. Early Career Investigator Showcases Applications (NIDA-NIAAA Frontiers in Addiction Research Mini-Convention)
Call For Applications. The 2022 NIDA-NIAAA Frontiers in Addiction Research Mini-Convention calls for applications for the Early Career Investigator Showcases (ECIS). The ECIS symposium provides a forum for scientific presentations by premier young and junior investigators working in the fields of alcohol and substance abuse and addiction research. This symposium will take place on Tuesday and Wednesday, November 1-2, 2022, during the Annual NIDA-NIAAA Frontiers in Addiction Research Mini-Convention. To apply, please complete the application form, include your Curriculum Vitae/Resume and list of publications, and send via email to (ECIS.Abstracts@seiservices.com) by Friday, September 2, 2022, 5:00 PM (EDT).
VI. NIDA Early Career Workshop at CPDD
The National Institute on Drug Abuse (NIDA) Early Career Symposium CPDD 2022, will be held this Saturday, June 11, 13:00 - 15:30 pm EDT. This Zoom webinar symposium will focus on career transition and the independence of early investigators. The speakers will incorporate strategies for writing successful NIH grant applications among other advice for early career scientists. This symposium has been developed to address issues identified in a recent survey of early-stage investigators, graduate and postdoctoral fellows, early-stage investigators, and newly established faculty. We look forward to your participation in this topical and timely NIDA symposium. Please register using the following link:
https://seiservices.zoom.us/webinar/register/WN_H_D2eWTQSHiQq5adYpDqGQ
-------
The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L
No comments:
Post a Comment